The influence of methylphenidate on the power spectrum of ADHD children -- an MEG study

Wienbruch, Christian; Paul, Isabella; Bauer, Susanne; Kivelitz, Hermann
January 2005
BMC Psychiatry;2005, Vol. 5, p29
Academic Journal
Background: The present study was dedicated to investigate the influence of Methylphenidate (MPH) on cortical processing of children who were diagnosed with different subtypes of Attention Deficit Hyperactivity Disorder (ADHD). As all of the previous studies investigating power differences in different frequency bands have been using EEG, mostly with a relatively small number of electrodes our aim was to obtain new aspects using high density magnetoencephalography (MEG). Methods: 35 children (6 female, 29 male) participated in this study. Mean age was 11.7 years (± 1.92 years). 17 children were diagnosed of having an Attention-Deficit/Hyperactivity Disorder of the combined type (ADHDcom, DSM IV code 314.01); the other 18 were diagnosed for ADHD of the predominantly inattentive type (ADHDin, DSM IV code 314.0). We measured the MEG during a 5 minute resting period with a I 48-channel magnetometer system (MAGNES™ 2500 WH, 4D Neuroimaging, San Diego, USA). Power values were averaged for 5 bands: Delta (D, 1.5-3.5 Hz), Theta (T, 3.5-7.5 Hz), Alpha (A, 7.5-12.5 Hz), Beta (B, 12.5-25 Hz) and Global (GL, 1.5-25 Hz).). Additionally, attention was measured behaviourally using the D2 test of attention with and without medication. Results: The global power of the frequency band from 1.5 to 25 Hz increased with MPH. Relative Theta was found to be higher in the left hemisphere after administration of MPH than before. A positive correlation was found between D2 test improvement and MPH-induced power changes in the Theta band over the left frontal region. A linear regression was computed and confirmed that the larger the improvement in D2 test performance, the larger the increase in Theta after MPH application. Conclusion: Main effects induced by medication were found in frontal regions. Theta band activity increased over the left hemisphere after MPH application. This finding contradicts EEG results of several groups who found lower levels of Theta power after MPH application. As relative Theta correlates with D2 test improvement we conclude that MEG provide complementary and therefore important new insights to ADHD.


Related Articles

  • Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Rhodes, Sinead M.; Coghill, David R.; Matthews, Keith // Psychopharmacology;2004, Vol. 175 Issue 3, p319 

    Presents a study which compared the performance of boys with attention deficit/hyperkinetic disorder on a spatial working memory task and on two non-working memory tasks with that of healthy boys. Impact of acute and chronic methylphenidate on performance of these tasks; Materials and methods;...

  • Is methylphenidate useful for treating adolescents with ADHD? Mott, Timothy F.; Leach, Laura // Journal of Family Practice;Aug2004, Vol. 53 Issue 8, p659 

    This article examines the effectiveness of methylphenidate in treating adolescents with attention deficit/hyperactivity disorder (ADHD). Though the immediate-release preparation is the best studied of methylphenidate formulations, extended-release methylphenidate has similar benefits, with a...

  • The Legacy Continues. Kessinger IV, A. Jay // Original Internist;Jun2011, Vol. 18 Issue 2, p43 

    The author discusses attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). He questions the medical community's assumption that these are due to brain chemical imbalances. The author also expresses concern over the use of...

  • The Effects of Methylphenidate on Various Components of Visual Attention in Children with Attention-Deficit Hyperactivity Disorder. Durukan, İbrahim; Türkbay, Tümer; Cöngöloğlu, Ayhan // Turkish Journal of Psychiatry;2008, Vol. 19 Issue 4, p1 

    Objective: Attention-deficit hyperactivity disorder (ADHD) is characterized by deficits and impairment in various components of visual attention. Methylphenidate (MPH) is the most commonly prescribed treatment for children with ADHD. The purpose of this study was to examine the effects of MPH on...

  • Chapter 6: CHANGES. Brinkerhoff, Shirley // Stuck on Fast Forward: Youth with Attention Deficit Hyper Activi;2004, p90 

    According to Peter R. Breggin, M.D., a psychiatrist and the founder of the International Center for the Study of Psychiatry and Psychology, a child who is diagnosed with attention-deficit hyperactivity disorder (ADHD) actually has other problems that should be diagnosed and treated. Ellen...

  • Efficacy and Safety of Ritalin[sup ®] LAâ„¢, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder. Biederman, Joseph; Quinn, Declan; Weiss, Margaret; Markabi, Sabri; Weidenman, Meredith; Edson, Kathryn; Karlsson, Goeril; Pohlmann, Harald; Wigal, Sharon // Pediatric Drugs;2003, Vol. 5 Issue 12, p833 

    Objective: To evaluate the safety and efficacy of extended-release methylphenidate with a bimodal profile using SODAS™ technology (Ritalin[sup ®] LA™) compared with placebo in children aged 6–14 years with attention deficit hyperactivity disorder (ADHD). Method: This was a...

  • Association of 4-Repeat Allele of the Dopamine D4 Receptor Gene Exon III Polymorphism and Response to Methylphenidate Treatment in Korean ADHD Children. Keun-Ah Cheon; Boong-Nyun Kim; Soo-Churl Cho // Neuropsychopharmacology;Jun2007, Vol. 32 Issue 6, p1377 

    In the present study, we investigated the association between the 4-repeat allele at the dopamine receptor D4 (DRD4) gene and the response to treatment with methylphenidate (MPH) in Korean children with attention deficit hyperactivity disorder (ADHD). The study subjects were 83 children with...

  • Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Tucha, Oliver; Prell, Sylvia; Mecklinger, Lara; Bormann-Kischkel, Christine; Kübber, Sabine; Linder, Martin; Walitza, Suzanne; Lange, Klaus W. // Psychopharmacology;Apr2006, Vol. 185 Issue 3, p315 

    Rationale: Methylphenidate (MPH) has been shown to be effective in the treatment of attention deficits in children with attention deficit hyperactivity disorder (ADHD). Although a variety of studies have been performed, there is little available information as to which components of attentional...

  • Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog. Giorgi, M.; Prise, U.; Soldani, G.; Neri, D.; Lavy, E. // Veterinary Research Communications;Jun2010, Vol. 34, p73 

    Methylphenidate (MPH) is an immediate-release (IR) or sustained-release (SR) drug used to treat attention-deficit hyperactivity disorder. Eight dogs were randomly assigned to two treatment groups, using an open, single-dose, two-treatment, two-period, randomized, crossover design. Each subject...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics